Yamashita Chikara, Funayama Manabu, Li Yuanzhe, Yoshino Hiroyo, Yamada Hitoshi, Seino Yusuke, Tomiyama Hiroyuki, Hattori Nobutaka
Department of Neurology, Juntendo University School of Medicine, 3-3-11 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Research Institute for Diseases of Old Age, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
J Neural Transm (Vienna). 2017 Apr;124(4):431-435. doi: 10.1007/s00702-016-1658-7. Epub 2016 Dec 9.
A recessive mutation in PLA2G6, which is known to cause infantile neuroaxonal dystrophy (INAD) and neurodegeneration associated with brain iron accumulation (NBIA), has recently been shown to be responsible for PARK14-linked dystonia-parkinsonism. To study the frequency of PLA2G6 mutations, including those caused by gene rearrangement in patients with parkinsonism, we performed direct sequencing and investigated copy number variations (CNVs) of this gene in 109 Japanese patients with parkinsonism. Direct sequencing revealed a homozygous mutation (c.1495G>A; p.A499T), which is likely to be pathogenic and is already registered as rs141045127, and two compound-heterozygous mutations we have previously reported. No CNVs in PLA2G6 were detected in our subjects. Our results suggest that CNV in PLA2G6 is rare in parkinsonism, at least in the Japanese population, in contrast to the reports of its frequency in INAD. Further large studies in various populations are warranted to elucidate what causes the difference in frequencies of PLA2G6 rearrangement mutations between INAD and dystonia-parkinsonism.
PLA2G6基因的隐性突变已知会导致婴儿神经轴索性营养不良(INAD)以及与脑铁沉积相关的神经退行性变(NBIA),最近研究表明该突变与PARK14连锁的肌张力障碍-帕金森综合征有关。为研究帕金森综合征患者中PLA2G6突变的频率,包括那些由基因重排引起的突变,我们对109例日本帕金森综合征患者进行了直接测序,并研究了该基因的拷贝数变异(CNV)。直接测序发现了一个纯合突变(c.1495G>A;p.A499T),该突变可能具有致病性,且已被注册为rs141045127,以及两个我们之前报道过的复合杂合突变。在我们的研究对象中未检测到PLA2G6的CNV。我们的结果表明,与INAD中该基因频率的报道相反,PLA2G6的CNV在帕金森综合征中很少见,至少在日本人群中如此。有必要在不同人群中开展进一步的大规模研究,以阐明INAD和肌张力障碍-帕金森综合征之间PLA2G6重排突变频率差异的原因。